0001493152-20-012572.txt : 20200702
0001493152-20-012572.hdr.sgml : 20200702
20200702181818
ACCESSION NUMBER: 0001493152-20-012572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200702
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cini John K.
CENTRAL INDEX KEY: 0001806526
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35570
FILM NUMBER: 201011334
MAIL ADDRESS:
STREET 1: C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC
STREET 2: 100 OVERLOOK CENTER
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001106838
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522102141
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 OVERLOOK CENTER
STREET 2: SUITE 102
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-375-2227
MAIL ADDRESS:
STREET 1: 100 OVERLOOK CENTER
STREET 2: SUITE 102
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: Chanticleer Holdings, Inc.
DATE OF NAME CHANGE: 20050510
FORMER COMPANY:
FORMER CONFORMED NAME: TULVINE SYSTEMS INC
DATE OF NAME CHANGE: 20000214
4
1
ownership.xml
X0306
4
2020-07-02
0
0001106838
Sonnet BioTherapeutics Holdings, Inc.
SONN
0001806526
Cini John K.
100 OVERLOOK CENTER, SUITE 102
PRINCETON,
NJ
08540
0
1
0
0
Chief Scientific Officer
Common Stock
2020-07-02
4
A
0
78214
0.00
A
238071
D
On July 2, 2020, the Reporting Person was granted 78,214 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.
/s/ John Harry Cross III, power of attorney
2020-07-02